DIS
62
2
MA
67
-5
URBN
66
2
CNP
50
-2
PLD
56
8
SWK
56
-6
ETR
68
-3
NRG
50
-2
CAH
60
2
HPE
70
2
DTE
38
-4
LNC
45
-4
GPC
40
2
PSA
58
5
COF
63
-4
STZ
58
3
OXY
55
6
NWS
79
-4
XRX
34
-3
EMN
50
-2
DIS
62
2
MA
67
-5
URBN
66
2
CNP
50
-2
PLD
56
8
SWK
56
-6
ETR
68
-3
NRG
50
-2
CAH
60
2
HPE
70
2
DTE
38
-4
LNC
45
-4
GPC
40
2
PSA
58
5
COF
63
-4
STZ
58
3
OXY
55
6
NWS
79
-4
XRX
34
-3
EMN
50
-2
Financhill
Back

Revance Therapeutics Vs. Dyne Therapeutics Industry Stock Comparison

Sell
15

RVNC
Revance Therapeutics

Last Price:
4.32
Seasonality Move:
7.02%
Buy
66

DYN
Dyne Therapeutics

Last Price:
30.40
Seasonality Move:
38.02%
Sell
15
Revance Therapeutics (RVNC) is a Sell

Is Revance Therapeutics a Buy, Sell or Hold?

  • The current Revance Therapeutics [RVNC] share price is $4.25. The Score for RVNC is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
  • RVNC is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
66
Dyne Therapeutics (DYN) is a Buy

Is Dyne Therapeutics a Buy, Sell or Hold?

  • The current Dyne Therapeutics [DYN] share price is $34.14. The Score for DYN is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
  • DYN is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

RVNC Stock Price Chart

What is Revance Therapeutics's stock price today?

  • The Revance Therapeutics share price today is $4.25
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RVNC is experiencing buying pressure, which is a positive indicator for future bullish movement.

DYN Stock Price Chart

What is Dyne Therapeutics's stock price today?

  • The Dyne Therapeutics share price today is $34.14
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DYN is experiencing buying pressure, which is a positive indicator for future bullish movement.

RVNC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.31 Sell
Relative Strength Index (14 RSI): 37.32 Sell
Chaikin Money Flow: 1491457 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (4.55 - 5.91) Sell
Bollinger Bands (100): (3.54 - 6.32) Sell

DYN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.99 Sell
Relative Strength Index (14 RSI): 60.64 Buy
Chaikin Money Flow: 1192325 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (28.99 - 33.51) Buy
Bollinger Bands (100): (31.49 - 42.59) Sell

RVNC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 4.84 Sell
20-day SMA: 5.23 Sell
50-day SMA: 5.53 Sell
200-day SMA: 4.65 Sell
8-day EMA: 4.61 Sell
20-day EMA: 5.06 Sell
50-day EMA: 5.24 Sell
200-day EMA: 6.16 Sell

DYN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 29.58 Buy
20-day SMA: 30.81 Buy
50-day SMA: 32.62 Buy
200-day SMA: 32.06 Buy
8-day EMA: 30.24 Buy
20-day EMA: 30.74 Buy
50-day EMA: 32.95 Buy
200-day EMA: 30.83 Buy

Revance Therapeutics Earnings Growth & RVNC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.31 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.38 per share, and an increase next year of $0.71 per share.

Dyne Therapeutics Earnings Growth & DYN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.54 per share, and an increase next year of $0.08 per share.

Revance Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Dyne Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):